Ads
related to: eosinophilic asthma treatment nucala 2 mg- Indications For NUCALA
Learn More About Various Approved
Indications For NUCALA & View PI.
- Dosing & Administration
Get Dosing & Administration
Information For NUCALA.
- How Does NUCALA Work?
Discover Facts Related To The MOA
Of NUCALA To Learn How It Works.
- Learn About NUCALA
Get Info About NUCALA To Share With
Your Patients & Request A Rep Today
- Clinical Trial Data
View Clinical Data & Information
About NUCALA To Learn More.
- NUCALA Patient Profiles
Physicians: Identify If NUCALA
Is Right For Your Patients.
- Indications For NUCALA
Search results
Results From The WOW.Com Content Network
Mepolizumab. Mepolizumab, sold under the brand name Nucala by GlaxoSmithKline, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome (HES). [ 5 ] It recognizes and blocks interleukin-5 (IL-5), a signalling protein of the immune system.
September 6, 2024 at 2:17 AM. (Reuters) -British drugmaker GSK said on Friday that its asthma drug, Nucala, met the main goal of a late-stage study in treating patients with chronic obstructive ...
Anti-asthmatic agents. Anti-asthmatic agents refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related ...
EXHALE-2: [5] a global Phase III clinical trial to evaluate the efficacy and safety of dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma, is currently recruiting people ≥12 years old with a documented physician diagnosis of asthma who require medium to high dose inhaled corticosteroids ...
Molar mass. 144 590.40 g·mol −1. Tezepelumab, sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma. [5][7][8][9] Tezepelumab blocks thymic stromal lymphopoietin (TSLP), [5] an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation. [10]
Treatment. corticosteroids. Eosinophilic bronchitis (EB) is a type of airway inflammation due to excessive mast cell recruitment and activation in the superficial airways as opposed to the smooth muscles of the airways as seen in asthma. [1][2] It often results in a chronic cough. [1] Lung function tests are usually normal. [1]
Ads
related to: eosinophilic asthma treatment nucala 2 mg